(Q37160085)

18 August 2017

Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm (English)

1 reference

18 August 2017

0 references

1 reference

6

Anu Chittenden

1 reference

18 August 2017

Jessica N Everett

1

1 reference

18 August 2017

Victoria M Raymond

2

1 reference

18 August 2017

Monica Dandapani

3

1 reference

18 August 2017

Monica Marvin

4

1 reference

18 August 2017

Wendy Kohlmann

5

1 reference

18 August 2017

Erika Koeppe

7

1 reference

18 August 2017

Shanna L Gustafson

8

1 reference

18 August 2017

Tobias Else

9

1 reference

18 August 2017

Douglas R Fullen

10

1 reference

18 August 2017

Timothy M Johnson

11

1 reference

18 August 2017

Sapna Syngal

12

1 reference

18 August 2017

Stephen B Gruber

13

1 reference

18 August 2017

Elena M Stoffel

14

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

18 August 2017

1 reference

18 August 2017

150

1 reference

18 August 2017

12

1 reference

18 August 2017

1315-1321

1 reference

Screening for Muir-Torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Lynch syndrome screening implementation: business analysis by a healthcare system.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Feasibility of screening for Lynch syndrome among patients with colorectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Cancer risk in mutation carriers of DNA-mismatch-repair genes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Multiple sebaceous tumors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Mismatch repair protein deficiency is common in sebaceous neoplasms and suggests the importance of screening for Lynch syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4977578

Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer

3 September 2018

1 reference

12 December 2020

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients

1 reference

12 December 2020

The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)

1 reference

12 December 2020

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer

1 reference

12 December 2020

Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test

1 reference

12 December 2020

The Cancer Family Syndrome Rare Cutaneous Phenotypic Linkage of Torre's Syndrome

1 reference

12 December 2020

MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir–Torre syndrome

1 reference

12 December 2020

10.1001/JAMADERMATOL.2014.1217

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference